Towards drugs of the future :: key issues in lead finding and lead optimization /
The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicinal chemistry with the...
Gespeichert in:
| Körperschaften: | , |
|---|---|
| Weitere Verfasser: | , |
| Format: | Elektronisch Tagungsbericht E-Book |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam :
IOS Press,
2008.
|
| Schriftenreihe: | Solvay Pharmaceuticals Conferences ;
v. 9. |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicinal chemistry with the emphasis on global challenges. |
| Beschreibung: | 1 online resource (ix, 129 pages) : illustrations (some color) |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781607503910 1607503913 9781441605535 1441605533 1586039490 9781586039493 6612070617 1282070614 9781282070615 9786612070617 6000012616 9786000012618 |
| ISSN: | 1566-7685 ; |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn608623513 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 090514s2008 ne a ob 101 0 eng d | ||
| 010 | |z 2008940898 | ||
| 040 | |a MERUC |b eng |e pn |c MERUC |d E7B |d OCLCQ |d IOSPR |d N$T |d EBLCP |d IDEBK |d NOH |d OCLCQ |d OCLCF |d OCLCQ |d OCLCO |d YDXCP |d OCL |d OCLCO |d OCLCQ |d AZK |d AGLDB |d MOR |d PIFAG |d ZCU |d MERUC |d OCLCQ |d U3W |d STF |d WRM |d OCLCQ |d VTS |d NRAMU |d OCLCA |d ICG |d INT |d VT2 |d OCLCQ |d WYU |d OCLCQ |d DKC |d OCLCQ |d M8D |d HS0 |d OCLCQ |d UKCRE |d VLY |d AJS |d OCLCO |d VHC |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ | ||
| 019 | |a 318064028 |a 491256973 |a 646807191 |a 961551352 |a 962622171 |a 988518607 |a 991954230 |a 1037935899 |a 1038658116 |a 1045439914 |a 1055359097 |a 1066611808 |a 1081223169 |a 1153488594 |a 1162236913 |a 1228581540 |a 1241891451 |a 1290110030 |a 1300547311 |a 1303395847 | ||
| 020 | |a 9781607503910 | ||
| 020 | |a 1607503913 | ||
| 020 | |a 9781441605535 |q (electronic bk.) | ||
| 020 | |a 1441605533 |q (electronic bk.) | ||
| 020 | |a 1586039490 | ||
| 020 | |a 9781586039493 | ||
| 020 | |z 9781586039493 | ||
| 020 | |a 6612070617 | ||
| 020 | |a 1282070614 | ||
| 020 | |a 9781282070615 | ||
| 020 | |a 9786612070617 | ||
| 020 | |a 6000012616 | ||
| 020 | |a 9786000012618 | ||
| 035 | |a (OCoLC)608623513 |z (OCoLC)318064028 |z (OCoLC)491256973 |z (OCoLC)646807191 |z (OCoLC)961551352 |z (OCoLC)962622171 |z (OCoLC)988518607 |z (OCoLC)991954230 |z (OCoLC)1037935899 |z (OCoLC)1038658116 |z (OCoLC)1045439914 |z (OCoLC)1055359097 |z (OCoLC)1066611808 |z (OCoLC)1081223169 |z (OCoLC)1153488594 |z (OCoLC)1162236913 |z (OCoLC)1228581540 |z (OCoLC)1241891451 |z (OCoLC)1290110030 |z (OCoLC)1300547311 |z (OCoLC)1303395847 | ||
| 037 | |a 978-1-58603-949-3 |b IOS Press |n http://www.iospress.nl | ||
| 050 | 4 | |a RS401 |b .S65 2007eb | |
| 072 | 7 | |a COM |x MED008000 |2 bisacsh | |
| 082 | 7 | |a 615/.19 |2 22 | |
| 049 | |a MAIN | ||
| 111 | 2 | |a Solvay Pharmaceuticals Conference on Medicinal Chemistry |d (2007 : |c Garmisch-Partenkirchen, Germany) |0 http://id.loc.gov/authorities/names/no2011019897 | |
| 245 | 1 | 0 | |a Towards drugs of the future : |b key issues in lead finding and lead optimization / |c edited by C.G. Kruse and H. Timmerman. |
| 260 | |a Amsterdam : |b IOS Press, |c 2008. | ||
| 300 | |a 1 online resource (ix, 129 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Solvay Pharmaceuticals Conferences, |x 1566-7685 ; |v v. 9 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Title page; Preface; List of Contributors; Contents; Conference Preface and Keynote Lecture; A Thermodynamic Platform for Drug Discovery and Optimization; Structure-Based Design: Past, Present, and Future; Sense and Nonsense in Drug Discovery: A Chemical Perspective; Synthesis at the Interface of Chemistry and Biology: How and Why?; Drug Design with ADME in Mind: Recent Paradigm Shifts in Drug Discovery; Hypothesis Generation for Scientific Discovery. Examples from the Use of KEM®, a Rule-Based Method for Multi-Objective Analysis and Optimization | |
| 505 | 8 | |a Does Size Matter? Facts and Thoughts on Recombinant DrugsCan Nanotechnology Improve the Oral Delivery of Therapeutic Proteins?; The Omeprazole Story: How Endurance in Research May Pay Off; Conceptual Design of Cannabinoid CB1 Receptor Antagonists; Author Index | |
| 520 | |a The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicinal chemistry with the emphasis on global challenges. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Pharmaceutical chemistry |v Congresses. | |
| 650 | 0 | |a Drug development |v Congresses. | |
| 650 | 0 | |a Pharmaceutical industry |v Congresses. | |
| 650 | 6 | |a Chimie pharmaceutique |v Congrès. | |
| 650 | 6 | |a Médicaments |x Développement |v Congrès. | |
| 650 | 6 | |a Industrie pharmaceutique |v Congrès. | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a BIOGRAPHY & AUTOBIOGRAPHY |x Medical. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Pharmaceutical chemistry |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |2 fast | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 700 | 1 | |a Kruse, C. G. |q (Chris G.), |d 1952- |1 https://id.oclc.org/worldcat/entity/E39PCjJ83DR7C7yR84KpVTrHFq |0 http://id.loc.gov/authorities/names/n2007038062 | |
| 700 | 1 | |a Timmerman, H. |q (Hendrick) |1 https://id.oclc.org/worldcat/entity/E39PCjM4RpjKXGPQv6WJ7vQQbd |0 http://id.loc.gov/authorities/names/n85276160 | |
| 710 | 2 | |a Solvay Pharmaceuticals. |0 http://id.loc.gov/authorities/names/n99036556 | |
| 776 | 0 | 8 | |i Print version: |a Solvay Pharmaceuticals Conference on Medicinal Chemistry (9th : 2007 : Garmisch-Partenkirchen, Germany). |t Towards drugs of the future. |d Amsterdam : IOS Press, 2008 |w (DLC) 2008940898 |
| 830 | 0 | |a Solvay Pharmaceuticals Conferences ; |v v. 9. |0 http://id.loc.gov/authorities/names/n2002014879 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=269153 |3 Volltext |
| 936 | |a BATCHLOAD | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL433455 | ||
| 938 | |a ebrary |b EBRY |n ebr10285492 | ||
| 938 | |a EBSCOhost |b EBSC |n 269153 | ||
| 938 | |a YBP Library Services |b YANK |n 3318086 | ||
| 938 | |a YBP Library Services |b YANK |n 3003073 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn608623513 |
|---|---|
| _version_ | 1816881717036711936 |
| adam_text | |
| any_adam_object | |
| author2 | Kruse, C. G. (Chris G.), 1952- Timmerman, H. (Hendrick) |
| author2_role | |
| author2_variant | c g k cg cgk h t ht |
| author_GND | http://id.loc.gov/authorities/names/n2007038062 http://id.loc.gov/authorities/names/n85276160 |
| author_corporate | Solvay Pharmaceuticals Conference on Medicinal Chemistry Garmisch-Partenkirchen, Germany Solvay Pharmaceuticals |
| author_corporate_role | |
| author_facet | Kruse, C. G. (Chris G.), 1952- Timmerman, H. (Hendrick) Solvay Pharmaceuticals Conference on Medicinal Chemistry Garmisch-Partenkirchen, Germany Solvay Pharmaceuticals |
| author_sort | Solvay Pharmaceuticals Conference on Medicinal Chemistry Garmisch-Partenkirchen, Germany |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RS401 |
| callnumber-raw | RS401 .S65 2007eb |
| callnumber-search | RS401 .S65 2007eb |
| callnumber-sort | RS 3401 S65 42007EB |
| callnumber-subject | RS - Pharmacy |
| collection | ZDB-4-EBA |
| contents | Title page; Preface; List of Contributors; Contents; Conference Preface and Keynote Lecture; A Thermodynamic Platform for Drug Discovery and Optimization; Structure-Based Design: Past, Present, and Future; Sense and Nonsense in Drug Discovery: A Chemical Perspective; Synthesis at the Interface of Chemistry and Biology: How and Why?; Drug Design with ADME in Mind: Recent Paradigm Shifts in Drug Discovery; Hypothesis Generation for Scientific Discovery. Examples from the Use of KEM®, a Rule-Based Method for Multi-Objective Analysis and Optimization Does Size Matter? Facts and Thoughts on Recombinant DrugsCan Nanotechnology Improve the Oral Delivery of Therapeutic Proteins?; The Omeprazole Story: How Endurance in Research May Pay Off; Conceptual Design of Cannabinoid CB1 Receptor Antagonists; Author Index |
| ctrlnum | (OCoLC)608623513 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic Conference Proceeding eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05653cam a2200865 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn608623513</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">090514s2008 ne a ob 101 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2008940898</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MERUC</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">MERUC</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">IOSPR</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">NOH</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">U3W</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">OCLCA</subfield><subfield code="d">ICG</subfield><subfield code="d">INT</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">HS0</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKCRE</subfield><subfield code="d">VLY</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VHC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">318064028</subfield><subfield code="a">491256973</subfield><subfield code="a">646807191</subfield><subfield code="a">961551352</subfield><subfield code="a">962622171</subfield><subfield code="a">988518607</subfield><subfield code="a">991954230</subfield><subfield code="a">1037935899</subfield><subfield code="a">1038658116</subfield><subfield code="a">1045439914</subfield><subfield code="a">1055359097</subfield><subfield code="a">1066611808</subfield><subfield code="a">1081223169</subfield><subfield code="a">1153488594</subfield><subfield code="a">1162236913</subfield><subfield code="a">1228581540</subfield><subfield code="a">1241891451</subfield><subfield code="a">1290110030</subfield><subfield code="a">1300547311</subfield><subfield code="a">1303395847</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781607503910</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1607503913</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781441605535</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1441605533</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1586039490</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781586039493</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781586039493</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6612070617</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282070614</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282070615</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786612070617</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6000012616</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786000012618</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)608623513</subfield><subfield code="z">(OCoLC)318064028</subfield><subfield code="z">(OCoLC)491256973</subfield><subfield code="z">(OCoLC)646807191</subfield><subfield code="z">(OCoLC)961551352</subfield><subfield code="z">(OCoLC)962622171</subfield><subfield code="z">(OCoLC)988518607</subfield><subfield code="z">(OCoLC)991954230</subfield><subfield code="z">(OCoLC)1037935899</subfield><subfield code="z">(OCoLC)1038658116</subfield><subfield code="z">(OCoLC)1045439914</subfield><subfield code="z">(OCoLC)1055359097</subfield><subfield code="z">(OCoLC)1066611808</subfield><subfield code="z">(OCoLC)1081223169</subfield><subfield code="z">(OCoLC)1153488594</subfield><subfield code="z">(OCoLC)1162236913</subfield><subfield code="z">(OCoLC)1228581540</subfield><subfield code="z">(OCoLC)1241891451</subfield><subfield code="z">(OCoLC)1290110030</subfield><subfield code="z">(OCoLC)1300547311</subfield><subfield code="z">(OCoLC)1303395847</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">978-1-58603-949-3</subfield><subfield code="b">IOS Press</subfield><subfield code="n">http://www.iospress.nl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS401</subfield><subfield code="b">.S65 2007eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">COM</subfield><subfield code="x">MED008000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Solvay Pharmaceuticals Conference on Medicinal Chemistry</subfield><subfield code="d">(2007 :</subfield><subfield code="c">Garmisch-Partenkirchen, Germany)</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2011019897</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Towards drugs of the future :</subfield><subfield code="b">key issues in lead finding and lead optimization /</subfield><subfield code="c">edited by C.G. Kruse and H. Timmerman.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Amsterdam :</subfield><subfield code="b">IOS Press,</subfield><subfield code="c">2008.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (ix, 129 pages) :</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Solvay Pharmaceuticals Conferences,</subfield><subfield code="x">1566-7685 ;</subfield><subfield code="v">v. 9</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Title page; Preface; List of Contributors; Contents; Conference Preface and Keynote Lecture; A Thermodynamic Platform for Drug Discovery and Optimization; Structure-Based Design: Past, Present, and Future; Sense and Nonsense in Drug Discovery: A Chemical Perspective; Synthesis at the Interface of Chemistry and Biology: How and Why?; Drug Design with ADME in Mind: Recent Paradigm Shifts in Drug Discovery; Hypothesis Generation for Scientific Discovery. Examples from the Use of KEM®, a Rule-Based Method for Multi-Objective Analysis and Optimization</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Does Size Matter? Facts and Thoughts on Recombinant DrugsCan Nanotechnology Improve the Oral Delivery of Therapeutic Proteins?; The Omeprazole Story: How Endurance in Research May Pay Off; Conceptual Design of Cannabinoid CB1 Receptor Antagonists; Author Index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicinal chemistry with the emphasis on global challenges.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical chemistry</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug development</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Chimie pharmaceutique</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Développement</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Industrie pharmaceutique</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Drug Guides.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BIOGRAPHY & AUTOBIOGRAPHY</subfield><subfield code="x">Medical.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacy.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Nursing</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical chemistry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kruse, C. G.</subfield><subfield code="q">(Chris G.),</subfield><subfield code="d">1952-</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjJ83DR7C7yR84KpVTrHFq</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2007038062</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Timmerman, H.</subfield><subfield code="q">(Hendrick)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjM4RpjKXGPQv6WJ7vQQbd</subfield><subfield code="0">http://id.loc.gov/authorities/names/n85276160</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Solvay Pharmaceuticals.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n99036556</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Solvay Pharmaceuticals Conference on Medicinal Chemistry (9th : 2007 : Garmisch-Partenkirchen, Germany).</subfield><subfield code="t">Towards drugs of the future.</subfield><subfield code="d">Amsterdam : IOS Press, 2008</subfield><subfield code="w">(DLC) 2008940898</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Solvay Pharmaceuticals Conferences ;</subfield><subfield code="v">v. 9.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2002014879</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=269153</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="936" ind1=" " ind2=" "><subfield code="a">BATCHLOAD</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL433455</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10285492</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">269153</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3318086</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3003073</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Conference papers and proceedings fast |
| genre_facet | Conference papers and proceedings |
| id | ZDB-4-EBA-ocn608623513 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:17:09Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/no2011019897 http://id.loc.gov/authorities/names/n99036556 |
| isbn | 9781607503910 1607503913 9781441605535 1441605533 1586039490 9781586039493 6612070617 1282070614 9781282070615 9786612070617 6000012616 9786000012618 |
| issn | 1566-7685 ; |
| language | English |
| oclc_num | 608623513 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (ix, 129 pages) : illustrations (some color) |
| psigel | ZDB-4-EBA |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | IOS Press, |
| record_format | marc |
| series | Solvay Pharmaceuticals Conferences ; |
| series2 | Solvay Pharmaceuticals Conferences, |
| spelling | Solvay Pharmaceuticals Conference on Medicinal Chemistry (2007 : Garmisch-Partenkirchen, Germany) http://id.loc.gov/authorities/names/no2011019897 Towards drugs of the future : key issues in lead finding and lead optimization / edited by C.G. Kruse and H. Timmerman. Amsterdam : IOS Press, 2008. 1 online resource (ix, 129 pages) : illustrations (some color) text txt rdacontent computer c rdamedia online resource cr rdacarrier Solvay Pharmaceuticals Conferences, 1566-7685 ; v. 9 Includes bibliographical references and index. Print version record. Title page; Preface; List of Contributors; Contents; Conference Preface and Keynote Lecture; A Thermodynamic Platform for Drug Discovery and Optimization; Structure-Based Design: Past, Present, and Future; Sense and Nonsense in Drug Discovery: A Chemical Perspective; Synthesis at the Interface of Chemistry and Biology: How and Why?; Drug Design with ADME in Mind: Recent Paradigm Shifts in Drug Discovery; Hypothesis Generation for Scientific Discovery. Examples from the Use of KEM®, a Rule-Based Method for Multi-Objective Analysis and Optimization Does Size Matter? Facts and Thoughts on Recombinant DrugsCan Nanotechnology Improve the Oral Delivery of Therapeutic Proteins?; The Omeprazole Story: How Endurance in Research May Pay Off; Conceptual Design of Cannabinoid CB1 Receptor Antagonists; Author Index The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicinal chemistry with the emphasis on global challenges. English. Pharmaceutical chemistry Congresses. Drug development Congresses. Pharmaceutical industry Congresses. Chimie pharmaceutique Congrès. Médicaments Développement Congrès. Industrie pharmaceutique Congrès. MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh BIOGRAPHY & AUTOBIOGRAPHY Medical. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Drug development fast Pharmaceutical chemistry fast Pharmaceutical industry fast Conference papers and proceedings fast Kruse, C. G. (Chris G.), 1952- https://id.oclc.org/worldcat/entity/E39PCjJ83DR7C7yR84KpVTrHFq http://id.loc.gov/authorities/names/n2007038062 Timmerman, H. (Hendrick) https://id.oclc.org/worldcat/entity/E39PCjM4RpjKXGPQv6WJ7vQQbd http://id.loc.gov/authorities/names/n85276160 Solvay Pharmaceuticals. http://id.loc.gov/authorities/names/n99036556 Print version: Solvay Pharmaceuticals Conference on Medicinal Chemistry (9th : 2007 : Garmisch-Partenkirchen, Germany). Towards drugs of the future. Amsterdam : IOS Press, 2008 (DLC) 2008940898 Solvay Pharmaceuticals Conferences ; v. 9. http://id.loc.gov/authorities/names/n2002014879 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=269153 Volltext |
| spellingShingle | Towards drugs of the future : key issues in lead finding and lead optimization / Solvay Pharmaceuticals Conferences ; Title page; Preface; List of Contributors; Contents; Conference Preface and Keynote Lecture; A Thermodynamic Platform for Drug Discovery and Optimization; Structure-Based Design: Past, Present, and Future; Sense and Nonsense in Drug Discovery: A Chemical Perspective; Synthesis at the Interface of Chemistry and Biology: How and Why?; Drug Design with ADME in Mind: Recent Paradigm Shifts in Drug Discovery; Hypothesis Generation for Scientific Discovery. Examples from the Use of KEM®, a Rule-Based Method for Multi-Objective Analysis and Optimization Does Size Matter? Facts and Thoughts on Recombinant DrugsCan Nanotechnology Improve the Oral Delivery of Therapeutic Proteins?; The Omeprazole Story: How Endurance in Research May Pay Off; Conceptual Design of Cannabinoid CB1 Receptor Antagonists; Author Index Pharmaceutical chemistry Congresses. Drug development Congresses. Pharmaceutical industry Congresses. Chimie pharmaceutique Congrès. Médicaments Développement Congrès. Industrie pharmaceutique Congrès. MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh BIOGRAPHY & AUTOBIOGRAPHY Medical. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Drug development fast Pharmaceutical chemistry fast Pharmaceutical industry fast |
| title | Towards drugs of the future : key issues in lead finding and lead optimization / |
| title_auth | Towards drugs of the future : key issues in lead finding and lead optimization / |
| title_exact_search | Towards drugs of the future : key issues in lead finding and lead optimization / |
| title_full | Towards drugs of the future : key issues in lead finding and lead optimization / edited by C.G. Kruse and H. Timmerman. |
| title_fullStr | Towards drugs of the future : key issues in lead finding and lead optimization / edited by C.G. Kruse and H. Timmerman. |
| title_full_unstemmed | Towards drugs of the future : key issues in lead finding and lead optimization / edited by C.G. Kruse and H. Timmerman. |
| title_short | Towards drugs of the future : |
| title_sort | towards drugs of the future key issues in lead finding and lead optimization |
| title_sub | key issues in lead finding and lead optimization / |
| topic | Pharmaceutical chemistry Congresses. Drug development Congresses. Pharmaceutical industry Congresses. Chimie pharmaceutique Congrès. Médicaments Développement Congrès. Industrie pharmaceutique Congrès. MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh BIOGRAPHY & AUTOBIOGRAPHY Medical. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Drug development fast Pharmaceutical chemistry fast Pharmaceutical industry fast |
| topic_facet | Pharmaceutical chemistry Congresses. Drug development Congresses. Pharmaceutical industry Congresses. Chimie pharmaceutique Congrès. Médicaments Développement Congrès. Industrie pharmaceutique Congrès. MEDICAL Drug Guides. MEDICAL Pharmacology. BIOGRAPHY & AUTOBIOGRAPHY Medical. MEDICAL Pharmacy. MEDICAL Nursing Pharmacology. Drug development Pharmaceutical chemistry Pharmaceutical industry Conference papers and proceedings |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=269153 |
| work_keys_str_mv | AT solvaypharmaceuticalsconferenceonmedicinalchemistrygarmischpartenkirchengermany towardsdrugsofthefuturekeyissuesinleadfindingandleadoptimization AT krusecg towardsdrugsofthefuturekeyissuesinleadfindingandleadoptimization AT timmermanh towardsdrugsofthefuturekeyissuesinleadfindingandleadoptimization AT solvaypharmaceuticals towardsdrugsofthefuturekeyissuesinleadfindingandleadoptimization |